| 发明名称 |
Use of C-C Chemokine Receptor Type 7 (CCR7) Inhibitors |
| 摘要 |
This application discloses ophthalmic formulations and methods for treating dry eye disease with a C-C chemokine receptor type 7 (CCR7) inhibitor. |
| 申请公布号 |
US2015307619(A1) |
申请公布日期 |
2015.10.29 |
| 申请号 |
US201314651991 |
申请日期 |
2013.12.13 |
| 申请人 |
THE SCHEPENS EYE RESEARCH INSTITUTE, INC. |
发明人 |
Dana Reza;Chauhan Sunil;Kodati Shilpa;Saban Daniel |
| 分类号 |
C07K16/28;C07K14/705;A61K47/48;A61K45/06;A61K31/7088;A61K39/395 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating ocular surface inflammatory disease comprising:
identifying a subject who has been diagnosed with an ocular surface inflammatory disease; and administering to an ocular or adnexal tissue a composition comprising an effective amount of a C-C chemokine receptor type 7 (CCR7) inhibitor. |
| 地址 |
Boston MA US |
